Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
148.5 USD | +3.78% | +3.08% | +25.31% |
May. 29 | BofA Securities Adjusts Crane Price Target to $165 From $140, Maintains Buy Rating | MT |
May. 27 | CR Double-Crane Pharmaceutical's Unit Gets Nod for Phloroglucinol Injection | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+25.31% | 8.18B | |
-16.94% | 12.14B | |
-7.81% | 6.33B | |
+42.14% | 2.12B | |
+5.78% | 1.55B | |
+11.55% | 909M | |
+3.43% | 893M | |
-7.88% | 662M | |
-12.73% | 622M | |
-27.32% | 381M |
- Stock Market
- Equities
- CR Stock
- News Crane Company
- CR Double-Crane Pharmaceutical's Unit Gets Nod to Trial New Pain Medication